Aaron Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 13, 2025, 8:02 pm

Competitors of Aaron Industries Ltd

All Competitor Stocks of Aaron Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:30 pm

Below is a detailed analysis of the quarterly data for Aaron Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 19.24 Cr.. The value appears to be declining and may need further review. It has decreased from 24.11 Cr. (Mar 2025) to 19.24 Cr., marking a decrease of 4.87 Cr..
• For Expenses, as of Jun 2025, the value is 15.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.07 Cr. (Mar 2025) to 15.58 Cr., marking a decrease of 3.49 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.66 Cr.. The value appears to be declining and may need further review. It has decreased from 5.04 Cr. (Mar 2025) to 3.66 Cr., marking a decrease of 1.38 Cr..
• For OPM %, as of Jun 2025, the value is 19.02%. The value appears to be declining and may need further review. It has decreased from 20.90% (Mar 2025) to 19.02%, marking a decrease of 1.88%.
• For Other Income, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.02 Cr..
• For Interest, as of Jun 2025, the value is 0.68 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.41 Cr. (Mar 2025) to 0.68 Cr., marking an increase of 0.27 Cr..
• For Depreciation, as of Jun 2025, the value is 0.94 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.45 Cr. (Mar 2025) to 0.94 Cr., marking an increase of 0.49 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.08 Cr.. The value appears to be declining and may need further review. It has decreased from 4.24 Cr. (Mar 2025) to 2.08 Cr., marking a decrease of 2.16 Cr..
• For Tax %, as of Jun 2025, the value is 49.04%. The value appears to be increasing, which may not be favorable. It has increased from 35.14% (Mar 2025) to 49.04%, marking an increase of 13.90%.
• For Net Profit, as of Jun 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 2.75 Cr. (Mar 2025) to 1.06 Cr., marking a decrease of 1.69 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.01. The value appears to be declining and may need further review. It has decreased from 2.63 (Mar 2025) to 1.01, marking a decrease of 1.62.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:48 am

Growth

Last Updated: September 4, 2025, 9:55 pm

Balance Sheet

Last Updated: November 9, 2025, 1:33 pm

Below is a detailed analysis of the balance sheet data for Aaron Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.47 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.47 Cr..
• For Reserves, as of Mar 2025, the value is 32.56 Cr.. The value appears strong and on an upward trend. It has increased from 25.37 Cr. (Mar 2024) to 32.56 Cr., marking an increase of 7.19 Cr..
• For Borrowings, as of Mar 2025, the value is 31.86 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 31.56 Cr. (Mar 2024) to 31.86 Cr., marking an increase of 0.30 Cr..
• For Other Liabilities, as of Mar 2025, the value is 7.94 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.27 Cr. (Mar 2024) to 7.94 Cr., marking an increase of 0.67 Cr..
• For Total Liabilities, as of Mar 2025, the value is 82.83 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 74.67 Cr. (Mar 2024) to 82.83 Cr., marking an increase of 8.16 Cr..
• For Fixed Assets, as of Mar 2025, the value is 24.88 Cr.. The value appears strong and on an upward trend. It has increased from 24.35 Cr. (Mar 2024) to 24.88 Cr., marking an increase of 0.53 Cr..
• For CWIP, as of Mar 2025, the value is 32.52 Cr.. The value appears strong and on an upward trend. It has increased from 26.90 Cr. (Mar 2024) to 32.52 Cr., marking an increase of 5.62 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 25.43 Cr.. The value appears strong and on an upward trend. It has increased from 23.42 Cr. (Mar 2024) to 25.43 Cr., marking an increase of 2.01 Cr..
• For Total Assets, as of Mar 2025, the value is 82.83 Cr.. The value appears strong and on an upward trend. It has increased from 74.67 Cr. (Mar 2024) to 82.83 Cr., marking an increase of 8.16 Cr..

Notably, the Reserves (32.56 Cr.) exceed the Borrowings (31.86 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Aaron Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.86. This value is within the healthy range. It has increased from 6.00 (Mar 24) to 7.86, marking an increase of 1.86.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.86. This value is within the healthy range. It has increased from 6.00 (Mar 24) to 7.86, marking an increase of 1.86.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.60. This value is within the healthy range. It has increased from 7.41 (Mar 24) to 9.60, marking an increase of 2.19.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.09. It has increased from 34.22 (Mar 24) to 41.09, marking an increase of 6.87.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.09. It has increased from 34.22 (Mar 24) to 41.09, marking an increase of 6.87.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.20. This value is within the healthy range. It has increased from 1.00 (Mar 24) to 1.20, marking an increase of 0.20.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 74.41. It has increased from 60.37 (Mar 24) to 74.41, marking an increase of 14.04.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.35. This value is within the healthy range. It has increased from 10.76 (Mar 24) to 14.35, marking an increase of 3.59.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.63. This value is within the healthy range. It has increased from 9.40 (Mar 24) to 12.63, marking an increase of 3.23.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.33. This value is within the healthy range. It has increased from 8.12 (Mar 24) to 11.33, marking an increase of 3.21.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.87. This value is within the healthy range. It has increased from 6.04 (Mar 24) to 7.87, marking an increase of 1.83.
• For PBDIT Margin (%), as of Mar 25, the value is 19.28. This value is within the healthy range. It has increased from 17.82 (Mar 24) to 19.28, marking an increase of 1.46.
• For PBIT Margin (%), as of Mar 25, the value is 16.97. This value is within the healthy range. It has increased from 15.56 (Mar 24) to 16.97, marking an increase of 1.41.
• For PBT Margin (%), as of Mar 25, the value is 15.22. This value is within the healthy range. It has increased from 13.44 (Mar 24) to 15.22, marking an increase of 1.78.
• For Net Profit Margin (%), as of Mar 25, the value is 10.57. This value exceeds the healthy maximum of 10. It has increased from 10.01 (Mar 24) to 10.57, marking an increase of 0.56.
• For Return on Networth / Equity (%), as of Mar 25, the value is 19.15. This value is within the healthy range. It has increased from 17.66 (Mar 24) to 19.15, marking an increase of 1.49.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.94. This value is within the healthy range. It has increased from 16.70 (Mar 24) to 20.94, marking an increase of 4.24.
• For Return On Assets (%), as of Mar 25, the value is 9.95. This value is within the healthy range. It has increased from 8.47 (Mar 24) to 9.95, marking an increase of 1.48.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.60 (Mar 24) to 0.42, marking a decrease of 0.18.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.74. This value is within the healthy range. It has decreased from 0.88 (Mar 24) to 0.74, marking a decrease of 0.14.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.11 (Mar 24) to 0.98, marking a decrease of 0.13.
• For Current Ratio (X), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 1.5. It has decreased from 1.47 (Mar 24) to 1.28, marking a decrease of 0.19.
• For Quick Ratio (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.46, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.81. This value is within the healthy range. It has increased from 2.86 (Mar 24) to 4.81, marking an increase of 1.95.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 12.70. This value is below the healthy minimum of 20. It has decreased from 15.86 (Mar 24) to 12.70, marking a decrease of 3.16.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 10.42. This value is below the healthy minimum of 20. It has decreased from 12.95 (Mar 24) to 10.42, marking a decrease of 2.53.
• For Earning Retention Ratio (%), as of Mar 25, the value is 87.30. This value exceeds the healthy maximum of 70. It has increased from 84.14 (Mar 24) to 87.30, marking an increase of 3.16.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 89.58. This value exceeds the healthy maximum of 70. It has increased from 87.05 (Mar 24) to 89.58, marking an increase of 2.53.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 11.04. This value is within the healthy range. It has increased from 8.38 (Mar 24) to 11.04, marking an increase of 2.66.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.05. This value is within the healthy range. It has increased from 5.71 (Mar 24) to 7.05, marking an increase of 1.34.
• For Enterprise Value (Cr.), as of Mar 25, the value is 371.39. It has increased from 302.09 (Mar 24) to 371.39, marking an increase of 69.30.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.77. This value exceeds the healthy maximum of 3. It has decreased from 4.78 (Mar 24) to 4.77, marking a decrease of 0.01.
• For EV / EBITDA (X), as of Mar 25, the value is 24.71. This value exceeds the healthy maximum of 15. It has decreased from 26.81 (Mar 24) to 24.71, marking a decrease of 2.10.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.39. This value exceeds the healthy maximum of 3. It has increased from 4.32 (Mar 24) to 4.39, marking an increase of 0.07.
• For Retention Ratios (%), as of Mar 25, the value is 87.29. This value exceeds the healthy maximum of 70. It has increased from 84.13 (Mar 24) to 87.29, marking an increase of 3.16.
• For Price / BV (X), as of Mar 25, the value is 7.95. This value exceeds the healthy maximum of 3. It has increased from 7.62 (Mar 24) to 7.95, marking an increase of 0.33.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.39. This value exceeds the healthy maximum of 3. It has increased from 4.32 (Mar 24) to 4.39, marking an increase of 0.07.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Strength and Weakness